Conference Reports for NATAP

Presented at the 22nd Conference of the Asian Pacific Association for the Study of the Liver (APASL) Taipei, Taiwan February 16-19, 2012 Back

DACLATASVIR (BMS-790052), AN NS5A REPLICATION COMPLEX INHIBITOR, IN COMBINATION WITH PEGINTERFERON ALPHA-2B AND RIBAVIRIN IN JAPANESE TREATMENT-NAIVE AND NONRESPONDER PATIENTS WITH CHRONIC HCV GENOTYPE 1 INFECTION       Reported by Jules Levin   22nd Conference of the Asian Pacific Association for the Study of the Liver (APASL 2012), Taipei International Convention Center, February 16-19, 2012   SUZUKI F,1 CHAYAMA K,2 KAWAKAMI Y,2 TOYOTA J,3 KARINO Y,3 MOCHIDA S,4 NAGOSHI S,4 HAYASHI N,5 TAKEHARA T,6 KUMADA H,1 1TORANOMON HOSPITAL, TOKYO, JAPAN; 2HIROSHIMA UNIVERSITY, HIROSHIMA, JAPAN; 3SAPPORO-KOUSEI GENERAL HOSPITAL, SAPPORO, JAPAN; 4SAITAMA MEDICAL UNIVERSITY, SAITAMA, JAPAN; 5KANSAI-ROUSAI HOSPITAL, AMAGASAKI, JAPAN; 6OSAKA UNIVERSITY, OSAKA, JAPAN